- Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
-
Lee MX, Tan DS
- KMID: 2431241
- J Gynecol Oncol.
- 2018 Nov;29(6):e96.
- doi: 10.3802/jgo.2018.29.e96
The 3-weekly regimen of carboplatin and paclitaxel is the backbone of first line adjuvant chemotherapy for advanced ovarian cancer. The landmark Japanese Gynaecologic Oncology Group (JGOG) 3016 study demonstrated significant... -
- CITED
-
- Close
- SHARE
-
- Close
